IPA Fibbing Right Now Needs 786 Hold?IPA is the latest retail banger this week after NURO and CEMI took center stage during the first half. I took out the fibs back to the previous lows and plotted against the ATH. Interesting levels formed which showed pivot support/resistance at the 786 fib line and the 618 maintaining a secondary level of importance. After failing to break and hold above it, longs may be looking to see this 786 fib level to hold as a new support. This move was on COVID news with "potential" in the headline. So take that FWIW. Also have the upcoming corporate call next week on the 28th.
" Over the last few days alone, we’ve seen seriously bullish action in the stock market. Today former penny stock ImmunoPrecise (NASDAQ:IPA) was the latest to grab attention from retail traders. On Monday (7/19), IPA stock was traded around $5 with a volume of fewer than 60,000 shares. Fast-forward to today (7/22), and IPA stock reached highs of $16.47 before the afternoon session got into full swing, with more than 60 million shares traded...This wasn’t an outlier either. Other stocks this week like Chembio Diagnostics, Inc. (NASDAQ:CEMI) and NeuroMetrix Inc. (NASDAQ:NURO) made parabolic moves as well. CEMI stock jumped from lows of $2.20 to highs of $6.95, while NURO stock jumped from around $3 on Monday to over $40 today. "
Quote Source: 7 Penny Stocks To Buy According To Analysts With Targets Up To 316%
Stockstowatch
CEMI Levels & Things To Consider NextCEMI made a heck of a run on 7/21 so I figured we should do a quick and dirty Fib Retracement. Using the most recent low as the anchor and the high from JUST before CEMI gapped down last June, the candles line up with some interesting levels. It looks like the 786 fib line has consistently held as major support before breaking down below it this last time around. One of the more consistent levels of resistance seems to have been around that 50 fib line. Whenever CEMI approached it or briefly tested it, it wasn't able to sustain price much longer if at all. Now that it has gone ap sh*t, there's a few things to keep in mind both technical and fundamental. First, technical, CEMI has broken firmly above the 50 fib so this would theoretically be a level to watch to confirm whether it becomes a new support or if it once again acts as resistance. Second, the next level, 236 fib, has only been a "major" resistance point 1 time, so whether that makes it "another level to watch" is to be seen but just in case, it could be another level to watch...
Now, after this move, I'm sure everyone is hyped BUT don't forget what was filed just 2 days ago...
" But…and there’s a but here…keep the company’s filings in mind. Big moves are great, but when companies raise capital, it can put a damper on things depending on the price that the money is raised at. A few days ago, the company filed for an at-the-market offering for up to $60 million. No pricing was disclosed in that 8-K filing . So no matter what analysts are saying, keep this in mind if CEMI is on your list of penny stocks to watch right now. " - Best Penny Stocks To Buy Now? Analysts See 85%-288% Upside In 3
You guessed it...an ATM offering for up to $60 mill. Aside from the technicals, it's important to keep this in mind because if there's an offering at a discount coming from this 8K, who knows what could happen in the market. But...live life one candle at a time I suppose. If CEMI is on your watch list these are all points to keep track of.
NURO Fibbing Right Now Or New Highs Next?I took the NURO chart out to 2019, which was the last time it traded around these levels. After plotting these fibs, wouldn't you know, the 236 and 382 lined up almost EXACTLY with today's action. The 382 could be an important level to watch as this was a prior area of "high traffic" and a support/resistance pivot in 2019. With volume surging, 382 fib line could be a key level t pay attention to.
**The big spike in trading action on July 20th stemmed from FDA news. NeuroMetrix announced that it received FDA Breakthrough Device Designation for treating fibromyalgia. Specifically, its Quell device garnered the interest of the stock market today. The device is non-invasive and is a nerve stimulator covered by 18 U.S. utility patents already. This Breakthrough Device Program aims to help patients gain quicker access to technologies like Quell that could provide more effective treatments.
“We are moving forward with a regulatory filing that could position us to launch Quell for this indication in the second half of next year.”
Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix
Later this week, the company releases its Q2 results. So if NURO stock is on your list right now, keep July 22nd in mind. The company will also host a conference call before the market opens on that day. Read More On NeuroMetrix .**
Quote Source: 4 Penny Stocks To Watch As Hedge Against Dogecoin Price Drop Today
NVDA going higher. BEAST STOCK!NVDA is splitting 4 to 1 on Tuesday 7/20. With earnings coming up and cheaper share prices after the split, you can bet investors will take this opportunity to grab shares while they are still cheap.
Anyways, Wave 4 bounced right at .382 retracement of wave 3 at 722.97. We also hit the bottom of the upper channel and found solid support there. We will probably get a run into earnings.
I have call options on NVDA
Between Two Fibs - AEMDAEMD seems to like this range between the 786 and 618 fib lines. The 618 has long-been a point of resistance on the chart. Meanwhile, the last few days have seen it test the 786 level but hold both above it AND its 50DMA. No news today but focus on biotechs thanks to CYTK earlier could be a sympathy trigger at play. Also with the Delta varient becoming "a thing," covid stocks in numerous stages of development are becoming more of a focus right now. We'll have to see if 786 fib+ 50DMA post a strong support level and if 618 will remain resistance if or when AEMD takes another swing at it.
50 Fib Level for CREGThis 50 fib level for CREG stock has been a pivot for months. No matter if it's broken out or slid lower, this area remains a magnet for the stock. With higher volume recently and a stronger uptrend on 7/19, 50 fib level is once again a point of interest and an important level to watch. Either way, it's come a long distance since it was on the list of penny stocks to watch .
Something to keep in mind, however, is that the company gained approval for the Authorized Share increase from 10m to 100m ( 7/9/2021 8K filing ). That can sometimes mean they need more wiggle room in their share structure to issue more stock. In line with this, it can also mean dilution depending on the inspiration behind the AH increase. At the very least, it's something to keep in the back of your head if you've got CREG on your watch list right now.
New Highs & Levels For CYTKCYTK put in a fresh high today which was rejected HARD almost immediately after. This came after the company announced positive topline results from 2 cohorts in its REDWOOD-HCM Phase 2 clinical trial of CK-3773274 (CK-274). This is the company’s investigational treatment targeting hypertrophic cardiomyopathy.
“The combined data from Cohorts 1 and 2 in REDWOOD-HCM met our high expectations for this trial of CK-274 in patients with obstructive HCM, given the observed onset of response to initiation of treatment, magnitude and breadth of response, reversibility of LVEF decreases, and favorable tolerability profile,” said Fady I. Malik, M.D., Ph.D., Cytokinetics’ Executive Vice President of Research & Development.
Looks like the 236 fib line - using lows from the major gap down - has been a pivot over the last year or so. CYTK tested that level on July 19th and bounced during the morning session. The big question is can it maintain this as a new support level or is it looking at another breakdown following this huge move?
"Thanks to these results, Cytokinetics expressed its anticipation of what its Phase 3 trial could bring to the table. Let’s put this into perspective. CYTK wasn’t any of the penny stocks that broke out last year. However, its valuation was a fraction of what it is today. Last October, CYTK stock was trading around $15 a share; more than 50% less than its value on July 19th. With that, attention is certainly on smaller biotech stocks right now."
Quote Source: Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech
CRTD Fib RetracementRight now with CRTD the 786 area has presented a relatively frequent area of "traffic" over the last few weeks. The sporadic breakouts show a clear area of resistance on the chart that it hasn't been able to break through. But the fact that it's gotten so heavily rejected puts attention at lower levels imo. Right now, CRTD pre market has show to test the 618 fib line. But after getting denied, the consolidation trend has it back below $4. With this latest bout of momentum it will be interesting to see if it comes back to test the 786 fib again or if it can regain momentum and retest 618 as resistance.
"traders on social media have circulated the stock as one with higher than average short interest. Other than that, there haven’t been any news headlines or filings released in conjunction with the latest market action. Considering that the potential catalyst could be technical in nature, it’s important to understand the dynamics at play. Lower float, higher short interest stocks can be incredibly volatile. While this latest bout of action has put bulls in control, any stall in this trend could see the opposite. So if CRTD stock is on your list right now, keep this in mind."
Quote Source: 4 Hot Penny Stocks To Watch After The 1,100% SGOC Stock Rally
AMC Fibonacci Levels Trend AnalysisThe cat's outta the bag with AMC ...it's a popular stock I guess (joking). But all jokes aside, the apes remain steadfast in their message but it's also time to revisit the technicals. After retracing from lows earlier this year, the Fib levels and current support/resistance areas on the chart seem to be lining up. The 50 Fib line is clearly a pivot that used to appear as a support level that AMC would test but not break below. Now that it has AND after breaking below the 50DMA, you can see that AMC has gotten denied multiple times not only at the 50 fib but also at the 50DMA. The big question for the week is can this fib area see a break and hold above or will the consolidation trend remain intact?
Obviously, apes will be apes and fight to the death but making money is nice too and understanding levels of potential support and resistance are important no matter if you're looking for profit targets or areas of potential buy opportunities. The bigger focus I think may be on what happens at the shareholder vote on the 29th at the AMC annual meeting. There were more details outlined in that proxy statement filed by AMC earlier this month .
MMAT Levels To Watch Right NowNot much happening with major Fib levels for MMAT however, that 200DMA seems to be acting as a potential level of support after falling below the 786 fib line. Meanwhile, there seems to be a level of resistance around $5 that has been the case several times over the last few months. The big question now is will the 200 hold this week?
Also have the SC13 G from last week to keep in mind. Nova Scotia Innovation Corporation (Operating as: Innovacorp) reported a 4.399 % stake in the company. This was an amended 13G and if you look back at the one posted on 7/7, you'll see Innovacorp reported a 6.558 % stake.
Who's WISHing for a Retest?WISH simple fib retracement using recent lows revealed some levels on the chart. The 786 fib has been a relatively frequent area of traffic for the stock. Meanwhile, 618 fib line was previously a level of support the continued to get tested but didn't break until recently. With WISH testing 618 as short-term resistance last week and 786 as potential support on Friday, it will be interesting to see if these levels remain the channel for WISH if/when it continues this consolidation trend.
Other than the usual social media excitement, also take a peek at the filings which should show the latest Form 4 coming out last week (7/15), which revealed that Brett Just Chief Accounting Officer, sold more shares. This adds to the growing number of Form 4s that have shown selling from insiders.
LQMT 618 Fib Support Or Fail?Simple chart breakdown using Fib retracement from the low last April ago shows some interesting levels for LQMT. 618 area has been a pivot over the last several months acting as support and resistance at times. The last few tests of this level didn't yield a successful breakthrough and hold but Friday's action seems to have sustained gains above the 618 Fib line. Furthermore the 50 fib has also been a higher area of traffic for the stock but only a few times has LQMT managed to hold consistently above that level.
That last 8k & update from July 9th seems to have been an initial catalyst for this latest move:
"Citing the company’s readiness for the next phase of its development and the ongoing restrictions on international travel, Professor Li reiterated his support for the Company and its management team. Following Professor Li’s resignation, the Board of Directors appointed Mr. Tony Chung as Interim CEO, and Mr. Isaac Bresnick as President. Mr. Chung will take responsibility for the strategic direction of the Company, while Mr. Bresnick will take responsibility for its day-to-day operations and customer service. Professor Li will stay on as the Company’s Chairman."
We'll have to see if the 618 fib line once again become the pivot point it has been and if LQMT can maintain levels above it or if it once again fails to hold.
SXTC back at an interesting level againSXTC had a big pop on 7/16 that took it up and through its 786 fib line. After doing a retracement using last September's lows, this level has shown to be an important pivot over the last few months. Late last year it was resistance in December and heading into the new year. Earlier on this year, it was broken through with the 618 fib becoming a very high traffic area that ultimately was support as SXTC broke out to over $5. The 618 level was a brief area of support in February that ultimately turned into resistance during the following months. If you take a look at where SXTC traded after there, the 786 area once again became a pivot area.
Now that it's back above it with higher volume, it will be interesting to see if the 786 fib can establish itself as a new support or if this is just another headfake leading to another breakdown.
"Based in China, SXTC is a pharmaceutical company developing traditional Chinese medicines. It manufactures, markets, and sells these products domestically, and is one of the only companies producing these types of compounds. The most recent news from China SXT came a few months ago when it announced a 4-1 reverse shares split. Since then however, not much news has come from the company.
So while today’s gain may be inexplicable with press releases, we could attribute it to SXTX’s placement as a meme stock. This means that it is frequently discussed on social media sites such as Reddit and Twitter. While this does make it highly volatile, it also adds potential for large gains (and losses)"
Quote Source: 4 High Volume Penny Stocks to Watch in July 2021
Woah G WOGI!WOGI hasn't attempted to test these levels since 2014! TLDR, I'm not gonna go all the way back to 2014 to DD the stock because this is just about identifying potential levels. I drew out the fib retracemtent using more recent lowest lows and the 2014 high and interestingly enough, the 786 fib line lined up with a pretty clear, recent level of resistance that WOGI juuuuuussst broke through. Meanwhile, the $0.11-$0.13 area isn't a "random" sticking point" either. Once again, go back to 2014 where WOGI broke out in a big way last and you'll see that this area was a recognizable pivot (resistance turned support turned resistance).
Now, does this mean it's set to fail again? that is going to be up to the market right now. All I'm doing is pointing out particular areas where there could be some interest to watch more closely than others. since the 618 fib is still a ways away, the fact that 11-13 cents was a previous area of "traffic" is too coincidental not to monitor it now that WOGI is trading at that same level. I think volume will be an important key to dictate the next leg higher or rejection and move lower. We'll see. But again if WOGI is on your list of penny stocks to watch right now, I think these could be interesting areas to monitor.
Management changes, cancellation of share issuance in April & plenty more news on WOGI here: pennystocks.com
CIDM Showing Signs Of LifeI drew the fib retracement starting from March 2020 lows and sure enough, it pinpointed a few key levels, the 786 fib line being one of them and CIDM is testing that as we speak. Depending on the volume and if this news event has some legs, CIDM could be one of the penny stocks to watch this week. A lot will likely come down to how it will close the day on 7/15/2021.
"Only a few days ago, it announced that it was forgiven for a $2.2 million Paycheck Protection Program (PPP) loan. East-West Bank paid off not only the loan in full but the principal and interest of the PPP loan as well. This is a big deal and should reflect positively on the companies balance sheet moving forward."
Quote Source: 7 Top Penny Stocks to Watch That You Probably Haven’t Heard Of
Then today, the company reported preliminary fiscal Q4 results.It said consolidated revenue came in at $8.3 million, with streaming channel sales up 197% versus the prior-year quarter and 39% sequentially over last quarter, according to a regulatory filing. Streaming/digital revenue grew to 75% of group sales in the quarter versus 48% in the prior-year quarter. Also, CIDM announced a payoff of the remainder of its Prospect Digital Cinema loan in the amount of approximately $3.5 Million, effective July 9, 2021. Revenue from the sale of certain digital cinema equipment enabled the debt reduction and balance sheet improvement.
"Action" for VERBSilly play on words but VERB is seeing some action, clearly, this month. Afterhours momentum took it higher early on during the 7/14 post-market session. Some interesting levels to note... I took the chart out to April 2019 after the big gap down to lay out the Fib retracement lines. In this case, it aligned with some pretty interesting chart levels that more or less have been pain points for VERB. Namely the 382 and 236 levels. First, 382 was a clear resistance over the last 18 months. You can see that VERB failed to break and hold above this line and sometimes even got denied RIGHT AT the .382 level. Looking at levels where it traded higher and you'll see why I labeled the 236 area as a pain point. Not once has it been able to establish itself as a "new support". But with multiple tests of this area, higher lows, higher highs, and higher volume over the last few days, what will this mean moving forward at least in the short term?
'As a Software-as-a-Service (SaaS) product provider, Verb is accessible on not only desktop devices but on mobile as well. The platform that Verb offers can integrate with popular software providers such as Oracle NetSuite, Salesforce, Odoo, Adobe Marketo, and Microsoft. There are many more integrations to come, but as of right now VERB remains committed to staying a leader in the tech industry. So, with a great deal of prospects on the horizon, is VERB stock worth watching?'
Quote Source: 5 Reddit Penny Stocks to Watch That Are Moving Right Now
BUT, don't forget about this if VERB's on your watch list right now: app.quotemedia.com
All told, there are several levels and things to keep in mind right now from both technical and fundamental angles.
Identifying Pain Points For USEGUSEG is a relatively flat stock for the most part. It's had its share of breakouts here and there but seems to call anything under the 786 fib home. Coincidentally, over the last year, this same 786 fib level has remained a pain point on the chart where USEG might break above it for a moment but fails to hold any significant level of support after doing so. That's what happened on 7/14 once again. BUT something that can also be seen is the very slight uptrend since November. When I say "uptrend, I'm referring to higher lows versus that green trendline. Will this get retested after today (7/14) or is there hope for another rally this week?
Similar short term pops have happened since last September most notably . That is when the stock popped to $18.57 then dropped like a 3 ton weight.
Any More Steam Left For XELA?XELA had a great run but is the steam running out? Lower volume day on 7/14 in tandem with the big drop. However, there are a few levels to keep track of. First, the 382 fib line. XELA was denied at this level twice this week with the second time resulting in the breakdown. BUT you've also got the 50 Fib,which has rarely acted as a major support BUT was a significant level of resistance in March and then you've got the 618 fib line, which was a much more consistent resistance level for the stock through the year. Thoughts are that volume could be important to watch as well as certain chart levels. Let's also not forget that these are some of the highest prices and volume that it's seen in some time....why keep that in mind?
"On June 30, 2021, Exela Technologies, Inc., a Delaware corporation (the “Company”), issued a press release announcing the launch of an offering for the sale of shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $150,000,000 (the “Shares”). The Shares will be sold pursuant to the at market issuance sales agreement, dated May 27, 2021 (the “Sales Agreement”), between the Company and B. Riley Securities, Inc. and Cantor Fitzgerald & Co. (each, an “Agent” and, together, the “Agents”). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K." (app.quotemedia.com)
No further updates on that topic have come up but something to keep in mind if you're watching XELA.
On July 12th, Exela announced that it has expanded its robotic process automation offerings with intelligent document processing. The President of Exela, Suresh Yannamani said, “Exela continues to iterate and advance solutions to meet our customers’ changing needs. The latest IDP and EON combination embraces the evolving work from anywhere environment that customers and their employees are embracing.”
Quote Source: Popular Reddit Penny Stocks to Buy? 4 to Watch As Summer Continues
CLVS 786 Fib Line Holding (For Now)Took the chart back out to March of last year to do a little fib retracement. Wouldn't you know, CLVS has been channel bound for a minute between the 618 and 786 fib lines with pretty clear support and resistance levels at each. Since it retraced back to the 786 again and is holding (for now), volume is likely going to be the "friend" or "foe" depending on how you're looking to trade this stock. You've also got the 50DMA to keep track of, which has also been a decent level of resistance over the past week or so.
Fundamentally, I'm looking to see if speculation starts building later down the line after they announced that they initiated sponsored clinical development of FAP-2286 with the Phase 1/2 LuMIERE clinical trial in patients with FAP-positive solid tumors which is now enrolling. Either way, cancer stocks seem to be picking up some steam . Whether it's targeted treatments or drug delivery technology, oncology is beginning to take its own slice of biotech lately.
Barrelin 2.0 - Without Rules There Is Chaos!I am now about 4 weeks into sharing my #Barrelin pattern and associated trading strategy mostly on Twitter.
In that time I have developed more regimented rules in hopes of automating the hunting if not the trades themselves. Here is the strategy as it stands today:
————-
Entry
4hr close above 75% on RSI (14)
Continuation
Hold EMA (8) on 4hr close
OR
1D close above 75% on RSI (14) (aka ‘Handoff to 1D’) AND Hold EMA (8) on 1D close
OR
1W close above 75% on RSI (14) (aka ‘Handoff to 1W’) AND Hold EMA (8) on 1W close
OR
1M close above 75% on RSI (14) (aka ‘Handoff to 1M’) AND Hold EMA (8) on 1M close
Exit
Close below EMA (8) on current timeframe that is #Barrelin
———
These handoffs are ideal but I am also starting to see, especially in stocks, the 4hr time frame is not only awkward with the limited trading but there are entries all the time on the higher timeframes without handoffs. The lower timeframes give an idea of momentum and personal preference can be used what timeframe to enter. This brings context to if you are “late” or not.
I have posted over 650 tweets in those 4 weeks so searching through #Barrelin will help give a better idea of the ridiculous gains with it.
Obviously there are fails and losers as well. I try to post these as well in order to see where the strategy can grow and evolve.
The biggest evolution I am currently working on is a trailing take profit with a re-entry. Not sure how hard that part will be to automate but might as well fine tune the idea as much as possible and see what comes of it.
Just with the shear volume of crypto and stocks I am following I have narrowed things down to just BTC pairs on Binance for crypto and no longer monitoring timeframes below the 4hr. It is personally impossible to still have any sort of life at that level.
As for stocks I have been transformed into a fanboy!!! I can’t believe it. The gains seem to be more consistent and much more explosive - at least in the current atmosphere. There is still crypto popping off but I recommend crypto lovers to give my timeline a visit to see the crazy gains.
I am loving the engagement with me and my strategy and I feel it is helping people which os my ultimate goal. I look forward to what the next 4 weeks brings as I try to scale this.
Thanks for reading all the way through. Time is precious and I appreciate you investing some of your time here.